AI agents are now taking over repetitive work, identifying issues humans may miss, and helping teams maintain testing speed ...
With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果